Sugi Predict

Sugi Predict / Compounds / SCHEMBL6989259

SCHEMBL6989259

SCHEMBL6989259

CC(C)(C)C(NC(=O)c1cccc(Cl)c1)Nc1c(Nc2cnccc2C(F)(F)F)c(=O)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ KCNJ11 Q14654 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ ABCC9 O60706 2/20 0.37
▸ ABCC8 Q09428 2/20 0.37
▸ KCNJ8 Q15842 2/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ S1PR2 O95136 2/20 0.37
▸ S1PR4 O95977 2/20 0.37
▸ S1PR3 Q99500 2/20 0.37
▸ LMNA P02545 2/20 0.36
▸ ALOX12 P18054 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6988616 0.89 ALDH1A1 (0.43) ALDH1A1MAPTGSK3AGSK3BMEN1
SCHEMBL6989909 0.84 KMT2A (0.41) ALDH1A1KCNJ11MAPTMEN1KMT2A
SCHEMBL6984652 0.83 ABCC9 (0.51) ALDH1A1KCNJ11MAPTABCC9ABCC8
SCHEMBL6987283 0.82 KMT2A (0.44) ALDH1A1KCNJ11ABCC9ABCC8KCNJ8
SCHEMBL6983246 0.81 KMT2A (0.44) ALDH1A1KCNJ11MAPTMEN1KMT2A
SCHEMBL4367789 0.81 GRM5 (0.45) ALDH1A1KCNJ11MAPTABCC9ABCC8
SCHEMBL6985814 0.80 KCNJ11 (0.52) ALDH1A1KCNJ11MAPTMEN1KMT2A
SCHEMBL6987149 0.78 MEN1 (0.41) ALDH1A1KCNJ11MAPTMEN1KMT2A
SCHEMBL6988592 0.77 KCNJ11 (0.54) ALDH1A1KCNJ11MAPTABCC9ABCC8
SCHEMBL6987437 0.77 KCNQ3 (0.54) ALDH1A1KCNJ11MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1358160-A1 AMINAL DIONES AS POTASSIUM CHANNEL OPENERS Abbott Laboratories (US) 2003-11-05 — — EP disclosed
US-6495576-B2 N-(1-((3,4-DIOXO-2-(3-PYRIDINYLAMINO)-1-CYCLOBUTEN-1-YL)AMINO) -2,2-DIMETHYLPROPYL)-4-METHYLBENZAMIDE FOR EXAMPLE; TREATING BLADDER OVERACTIVITY, BENIGN PROSTATIC HYPERPLASIA, PREMATURE LABOR, AND SEXUAL DISORDERS ABBOTT LABORATORIES 2002-12-17 — — US disclosed
US-20020165264-A1 Aminal diones as potassium channel openers ABBOTT LABORATORIES 2002-11-07 — — US disclosed
US-20020147230-A1 Aminal Diones as potassium channel openers ABBOTT LABORATORIES 2002-10-10 — — US disclosed
WO-2002062761-A1 AMINAL DIONES AS POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2002-08-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147230-A1 Aminal Diones as potassium channel openers KCNJ2, KCNJ11, KCNH1 ALDH1A1 132/4885KCNJ11 2/4885MAPT 3949/4885
US-20020165264-A1 Aminal diones as potassium channel openers KCNJ2, KCNJ11, KCNH1 ALDH1A1 132/4885KCNJ11 2/4885MAPT 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.